Oppenheimer Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,777
Closed -$275K 1189
2024
Q2
$275K Sell
5,777
-4,049
-41% -$193K ﹤0.01% 998
2024
Q1
$426K Sell
9,826
-723
-7% -$31.3K 0.01% 876
2023
Q4
$534K Sell
10,549
-419
-4% -$21.2K 0.01% 849
2023
Q3
$498K Sell
10,968
-51
-0.5% -$2.31K 0.01% 848
2023
Q2
$452K Sell
11,019
-36
-0.3% -$1.48K 0.01% 882
2023
Q1
$395K Buy
11,055
+686
+7% +$24.5K 0.01% 901
2022
Q4
$392K Sell
10,369
-465
-4% -$17.6K 0.01% 912
2022
Q3
$479K Sell
10,834
-69
-0.6% -$3.05K 0.01% 846
2022
Q2
$403K Sell
10,903
-92
-0.8% -$3.4K 0.01% 909
2022
Q1
$407K Buy
10,995
+1,213
+12% +$44.9K 0.01% 962
2021
Q4
$297K Sell
9,782
-1,100
-10% -$33.4K ﹤0.01% 1077
2021
Q3
$365K Buy
10,882
+165
+2% +$5.53K 0.01% 1007
2021
Q2
$427K Sell
10,717
-219
-2% -$8.73K 0.01% 993
2021
Q1
$491K Buy
10,936
+746
+7% +$33.5K 0.01% 918
2020
Q4
$577K Sell
10,190
-1,086
-10% -$61.5K 0.01% 841
2020
Q3
$535K Sell
11,276
-671
-6% -$31.8K 0.01% 796
2020
Q2
$705K Sell
11,947
-276
-2% -$16.3K 0.01% 699
2020
Q1
$577K Sell
12,223
-440
-3% -$20.8K 0.01% 688
2019
Q4
$765K Sell
12,663
-305
-2% -$18.4K 0.02% 699
2019
Q3
$777K Sell
12,968
-845
-6% -$50.6K 0.02% 686
2019
Q2
$888K Sell
13,813
-787
-5% -$50.6K 0.02% 651
2019
Q1
$1.19M Sell
14,600
-193
-1% -$15.7K 0.03% 559
2018
Q4
$800K Sell
14,793
-346
-2% -$18.7K 0.02% 631
2018
Q3
$781K Sell
15,139
-6,595
-30% -$340K 0.02% 685
2018
Q2
$905K Sell
21,734
-1,204
-5% -$50.1K 0.02% 623
2018
Q1
$1.01M Buy
22,938
+804
+4% +$35.4K 0.03% 596
2017
Q4
$1.12M Hold
22,134
0.03% 563
2017
Q3
$1.12M Buy
22,134
+632
+3% +$32.1K 0.03% 566
2017
Q2
$1.09M Sell
21,502
-1,367
-6% -$69.6K 0.03% 555
2017
Q1
$919K Buy
+22,869
New +$919K 0.03% 597